Properdin binding to complement activating surfaces depends on initial C3b deposition
Morten Harboe, Christina Johnson, Stig Haugset Nymo et al. · Proceedings of the National Academy of Sciences · 2017
Two functions have been assigned to properdin; stabilization of the alternative convertase, C3bBb, is well accepted, whereas the role of properdin as pattern recognition molecule is controversial. The presence of nonphysiological aggregates in purified properdin preparations and experimental models that do not allow discrimination between the initial binding of properdin and binding secondary to C3b deposition is a critical factor contributing to this controversy. In previous work, by inhibiting C3, we showed that properdin binding to zymosan and Escherichia coli is not a primary event, but rather is solely dependent on initial C3 deposition. In the present study, we found that properdin in human serum bound dose-dependently to solid-phase myeloperoxidase. This binding was dependent on C3 activation, as demonstrated by the lack of binding in human serum with the C3-inhibitor compstatin Cp40, in C3-depleted human serum, or when purified properdin is applied in buffer. Similarly, binding of properdin to the surface of human umbilical vein endothelial cells or Neisseria meningitidis after incubation with human serum was completely C3-dependent, as detected by flow cytometry. Properdin, which lacks the structural homology shared by other complement pattern recognition molecules and has its major function in stabilizing the C3bBb convertase, was found to bind both exogenous and endogenous molecular patterns in a completely C3-dependent manner. We therefore challenge the view of properdin as a pattern recognition molecule, and argue that the experimental conditions used to test this hypothesis should be carefully considered, with emphasis on controlling initial C3 activation under physiological conditions.
Cited by 65 works. doi:10.1073/pnas.1612385114 Open-access PDF
Authors
- Morten Harboe
- Stig Haugset Nymo
- Karin Ekholt
- Camilla Schjalm
- Julie Katrine Lindstad
- Anne M. Pharo
- Bernt Christian Hellerud
- Kristina Nilsson Ekdahl
- Tom Eirik Mollnes
- Per H. Nilsson
References
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIA
- The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune Phenomena
- Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
- Properties of Highly Purified Human Properdin
- Evidence for presence of an internal thiolester bond in third component of human complement.
- Complement System Part I – Molecular Mechanisms of Activation and Regulation
- Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex
- Structures of complement component C3 provide insights into the function and evolution of immunity
- Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
- Monoclonal Antibodies Recognizing a Neoantigen of Poly(C9) Detect the Human Terminal Complement Complex in Tissue and Plasma